Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats

Critical Care

Volumn 14, Issue 5, 2010, Pages

  Ganster, Frédérique ^a,b,f   Burban, Mélanie ^a   de la Bourdonnaye, Mathilde ^a   Fizanne, Lionel ^a   Douay, Olivier ^a   Loufrani, Laurent ^c   Mercat, Alain ^a,b   Calès, Paul ^a,b   Radermacher, Peter ^d   Henrion, Daniel ^c   Asfar, Pierre ^a,b   Meziani, Ferhat ^b,e,f  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GA BINDING PROTEIN; HEME OXYGENASE 1; HEME OXYGENASE 2; HYDROGEN SULFIDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SODIUM HYDROSULFIDE; SUPEROXIDE; UNCLASSIFIED DRUG; AUTACOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ARTIFICIAL VENTILATION; CAROTID ARTERY FLOW; CONTROLLED STUDY; DRUG EFFECT; ELECTRON SPIN RESONANCE; HEART; HEMODYNAMICS; HEMORRHAGIC SHOCK; INFLAMMATION; ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; RESUSCITATION; WESTERN BLOTTING; ANIMAL; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; PHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; HEMODYNAMICS; HYDROGEN SULFIDE; INFLAMMATION MEDIATORS; MALE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 77956479162     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9257     Document Type: Article

References (41)

1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006, 60:S3-11. 10.1097/01.ta.0000199961.02677.19, 16763478.
2. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193. 10.1097/00005373-199502000-00006, 7869433.
3. Rushing GD, Britt LD. Reperfusion injury after hemorrhage: a collective review. Ann Surg 2008, 247:929-937. 10.1097/SLA.0b013e31816757f7, 18520219.
4. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345:588-595. 10.1056/NEJMra002709, 11529214.
5. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001, 94:1133-1138. 10.1097/00000542-200106000-00030, 11465607.
6. Couch L, Martin L, Rankin N. Near death episode after exposure to toxic gases from liquid manure. N Z Med J 2005, 118:U1414.
7. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J 2002, 16:1792-1798. 10.1096/fj.02-0211hyp, 12409322.
8. Lowicka E, Beltowski J. Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. Pharmacol Rep 2007, 59:4-24.
9. Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-to-bedside review: Hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care 2009, 13:213. 10.1186/cc7700, 2717401, 19519960.
10. Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science 2005, 308:518. 10.1126/science.1108581, 15845845.
11. Blackstone E, Roth MB. Suspended animation-like state protects mice from lethal hypoxia. Shock 2007, 27:370-372. 10.1097/SHK.0b013e31802e27a0, 17414418.
12. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007, 6:917-935. 10.1038/nrd2425, 17948022.
13. Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1193-L1201. 10.1152/ajplung.00489.2005, 16428267.
14. Kubo S, Kurokawa Y, Doe I, Masuko T, Sekiguchi F, Kawabata A. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology 2007, 241:92-97. 10.1016/j.tox.2007.08.087, 17888559.
15. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, Moore PK. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br J Pharmacol 2006, 149:625-634. 10.1038/sj.bjp.0706906, 2014646, 17016507.
16. Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB. Surviving blood loss using hydrogen sulfide. J Trauma 2008, 65:183-188. 10.1097/TA.0b013e3181507579, 18580516.
17. Mok YY, Atan MS, Yoke PC, Zhong JW, Bhatia M, Moochhala S, Moore PK. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 2004, 143:881-889. 10.1038/sj.bjp.0706014, 1575944, 15504752.
18. Wiggers C. Present status of shock problem. Physiol Rev 1942, 22:74-123.
19. Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 2007, 171:1753-1761. 10.2353/ajpath.2007.070316, 2111100, 17991713.
20. Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 2005, 288:R243-R252.
21. Koenitzer JR, Isbell TS, Patel HD, Benavides GA, Dickinson DA, Patel RP, Darley-Usmar VM, Lancaster JR, Doeller JE, Kraus DW. Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol 2007, 292:H1953-H1960. 10.1152/ajpheart.01193.2006, 17237242.
22. Simon F, Giudici R, Duy CN, Schelzig H, Oter S, Groger M, Wachter U, Vogt J, Speit G, Szabo C, Radermacher P, Calzia E. Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. Shock 2008, 30:359-364. 10.1097/SHK.0b013e3181674185, 18323742.
23. Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD, Ichinose F, Zapol WM. Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 2008, 108:659-668. 10.1097/ALN.0b013e318167af0d, 2838418, 18362598.
24. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007, 104:15560-15565. 10.1073/pnas.0705891104, 2000503, 17878306.
25. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 2006, 41:106-119. 10.1016/j.freeradbiomed.2006.03.021, 16781459.
26. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006, 20:2118-2120. 10.1096/fj.06-6270fje, 16912151.
27. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 2007, 232:138-146. 10.1016/j.tox.2006.12.023, 17276573.
28. Jeong SO, Pae HO, Oh GS, Jeong GS, Lee BS, Lee S, Kim DY, Rhew HY, Lee KM, Chung HT. Hydrogen sulfide potentiates interleukin-1β-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 2006, 345:938-944. 10.1016/j.bbrc.2006.05.002, 16707097.
29. Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, Moore PK. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 2008, 117:2351-2360. 10.1161/CIRCULATIONAHA.107.753467, 18443240.
30. Esechie A, Kiss L, Olah G, Horvath EM, Hawkins H, Szabo C, Traber DL. Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond) 2008, 115:91-97. 10.1042/CS20080021, 18315525.
31. Maines MD, Mayer RD, Ewing JF, McCoubrey WK. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J Pharmacol Exp Ther 1993, 264:457-462.
32. Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008, 88:611-638. 10.1152/physrev.00025.2007, 18391175.
33. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003, 55:551-571. 10.1124/pr.55.3.5, 12869663.
34. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C. Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 2009, 31:267-274. 10.1097/SHK.0b013e318180ff89, 18636044.
35. Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002, 277:42769-42774. 10.1074/jbc.M206911200, 12198130.
36. Tamion F, Richard V, Bonmarchand G, Leroy J, Lebreton JP, Thuillez C. Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock. Am J Respir Crit Care Med 2001, 164:1933-1938.
37. Tripatara P, Sa PN, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown PA, Yaqoob MM, Fantozzi R, Thiemermann C. Generation of endogenous hydrogen sulfide by cystathionine-γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008, 88:1038-1048. 10.1038/labinvest.2008.73, 18679378.
38. Patel NS, Brancaleone V, Renshaw D, Rocha J, Sepodes B, Mota-Filipe H, Perretti M, Thiemermann C. Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol 2009, 606:205-209. 10.1016/j.ejphar.2009.01.041, 19374832.
39. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 2006, 26:154-161. 10.1097/01.shk.0000225722.56681.64, 16878023.
40. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 2008, 295:H801-H806. 10.1152/ajpheart.00377.2008, 2519205, 18567706.
41. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabó C, Sellke FW. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 2008, 33:906-913. 10.1016/j.ejcts.2008.01.047, 2424271, 18314343.